An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality
Open Access
- 1 October 2001
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 38 (10) , 674-679
- https://doi.org/10.1136/jmg.38.10.674
Abstract
OBJECTIVE Early research into Wolf-Hirschhorn syndrome (WHS) described a high mortality and no relationship between deletion size and phenotype. This may need to be revised in the light of improved cytogenetic resolution and medical care. We have collected epidemiological data to allow the calculation of birth incidence and mortality figures. In addition, we have investigated the possibility of a relationship between deletion size and mortality. METHOD Information relating to past and present cases diagnosed in the UK was collected by multiple ascertainment. RESULTS A total of 159 cases were collected. The status (alive or dead) was determined for 146, of whom 96 are alive, 37 had died, and 13 were detected on prenatal diagnostic tests. A minimum birth incidence of 1 in 95 896 was calculated. The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132). Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age. A comparison of survival curves for de novo deletions and translocations did not show a statistically significant difference (p=0.11). The median survival time for de novo deletions was 34+ years while for translocation cases it was 18+ years. CONCLUSIONS The mortality rate is lower than previously reported. There is a statistically significant relationship between deletion size and overall risk of death in de novo deletion cases. The difference in survival curves between de novo deletions and translocations is not statistically significant.Keywords
This publication has 17 references indexed in Scilit:
- Effect of the size of the deletion and clinical manifestation in Wolf-Hirschhorn syndrome: analysis of 13 patients with a de novo deletionEuropean Journal of Human Genetics, 2000
- WHSC1, a 90 kb SET Domain-Containing Gene, Expressed in Early Development and Homologous to a Drosophila Dysmorphy Gene Maps in the Wolf-Hirschhorn Syndrome Critical Region and is Fused to IgH in t(1;14) Multiple MyelomaHuman Molecular Genetics, 1998
- Translocations involving 4p16.3 in three families: deletion causing the Pitt-Rogers-Danks syndrome and duplication resulting in a new overgrowth syndrome.Journal of Medical Genetics, 1997
- A Transcript Map of the Newly Defined 165 kb Wolf-Hirschhorn Syndrome Critical RegionHuman Molecular Genetics, 1997
- Summary of the 1993 ASHG ancillary meeting “recent research on chromosome 4p syndromes and genes”American Journal of Medical Genetics, 1995
- Molecular characterisation of chromosome 4p deletions resulting in Wolf-Hirschhorn syndrome.Journal of Medical Genetics, 1994
- Statistics in Medicine: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and ratesBMJ, 1988
- A taxonomic approach to the del(4p) phenotypeAmerican Journal of Medical Genetics, 1985
- The Wolf‐Hirschhorn syndromeClinical Genetics, 1980
- Wolf-Hirschhorn syndrome associated with an unusual abnormality of chromosome no. 4.Journal of Medical Genetics, 1970